help button home button Biophys. J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Biophys. J. BioFAST: First Published March 13, 2008. doi:10.1529/biophysj.107.126896
© 2008 by the Biophysical Society.


A more recent version of this article appeared on June 15, 2008.
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
biophysj.107.126896v1
94/12/4737    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pérez-Berná, A. J
Right arrow Articles by Villalaín, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pérez-Berná, A. J
Right arrow Articles by Villalaín, J.

MEMBRANES

Interaction of the most membranotropic region of the HCV E2 envelope glycoprotein with membranes. Biophysical characterization

Ana J Pérez-Berná 1, Jaime Guillén 1, Miguel R Moreno 2, Ana I Gómez-Sànchez 2, Georg Pabst 3, Peter Laggner 3 and José Villalaín 4*

1 Universidad "Miguel Hernández"
2 Universidad "Miguel Hernàndez"
3 Austrian Academy Sciences Graz
4 Universidad Miguel Hernandez /Campus de Elche

* To whom correspondence should be addressed. E-mail: jvillalain{at}umh.es.

Submitted on December 3, 2007
Revised on January 24, 2008
Accepted on 21 February 2008


   Abstract
The previously identified membrane-active regions of the HCV E1 and E2 envelope glycoproteins led us to identify different segments which might be implicated in viral membrane fusion, membrane interaction and/or protein-protein binding. HCV E2 glycoprotein contains one of the most membranotropic segments, segment 603-634, which has been implicated in CD81 binding, E1/E2 and E2/E2 dimerization as well as membrane fusion. Consequently, we have carried out a study of the binding and interaction with the lipid bilayer of a peptide corresponding to segment 603-634, peptide E2FP, as well as the structural changes which take place in both the peptide and the phospholipid molecules induced by membrane binding through a series of complementary experiments. Here we demonstrate that peptide E2FP binds to and interacts with phospholipid model membranes, modulates the polymorphic phase behavior of membrane phospholipids, it is localized in a shallow position in the membrane and it is probably oligomerized in the presence of membranes. These data support its role in HCV-mediated membrane fusion, and would sustain the notion that this segment of the E2 envelope glycoprotein, together with other segments of E2 and E1 glycoproteins, provide the driving force for the merging of the viral and target cell membranes.

Key Words: HCV E2 glycoprotein, Membrane fusion, Peptide-lipid interaction







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Biophysical Society.